{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:05:16Z","timestamp":1789517116829,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["23ZR1427500"],"award-info":[{"award-number":["23ZR1427500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The primary systemic treatment for advanced colorectal cancer (CRC) is chemotherapy, but inevitable drug resistance leads to poor prognosis. Cancer stem cells (CSCs) are recognized as significant contributors to chemotherapy resistance, yet the mechanisms underlying their ability to induce widespread resistance across tumor cell populations remain poorly understood. In this study, we demonstrate a novel mechanism by which colorectal CSC-like spheroid cells (CCSCs) drive chemotherapy resistance through the release of small extracellular vesicles (sEVs) enriched with highly phosphorylated insulin-like growth factor binding protein-3 (IGFBP3) into the tumor microenvironment (TME). While cell-free IGFBP3 or endogenous IGFBP3 directly induces apoptosis in tumor cells, IGFBP3 originating from quiescent CCSCs functions through an epidermal growth factor receptor (EGFR)-dependent pathway to promote chemotherapy resistance. Mechanistically, the protein kinase VRK2, which is highly enriched in CCSCs, leads to the phosphorylation of IGFBP3 at the S201 site. This phosphorylation enables IGFBP3 to bind to EGFR, facilitating its sorting and subsequent recruitment into sEVs. Both EGFR and phosphorylated IGFBP3 are co-delivered via sEVs to recipient tumor cells, where they inhibit chemotherapy-induced DNA damage and promote resistance. Importantly, siRNA targeting VRK2 or the inhibitor D4476 significantly reduced IGFBP3 phosphorylation and its incorporation into sEVs, thereby reversing chemotherapy resistance. These findings highlight the dual role of IGFBP3 in CRC and provide critical insights into the core mechanism by which CCSCs drive chemotherapy resistance through EGFR and sEVs-mediated signaling, offering a novel therapeutic approach for personalized treatment of CRC.<\/jats:p>","DOI":"10.1038\/s41419-026-09009-0","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:06:09Z","timestamp":1782738369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EGFR-dependent delivery of phosphorylated IGFBP3 by cancer stem cells drives chemotherapy resistance in colorectal cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Xinyu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-4137","authenticated-orcid":false,"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-6315","authenticated-orcid":false,"given":"Beibei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiewei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-7110","authenticated-orcid":false,"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-7271","authenticated-orcid":false,"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"9009_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"9009_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22.","journal-title":"Signal Transduct Target Ther"},{"key":"9009_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02028-5","volume":"23","author":"R Bharti","year":"2024","unstructured":"Bharti R, Dey G, Khan D, Myers A, Huffman OG, Saygin C, et al. Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer. Mol Cancer. 2024;23:121.","journal-title":"Mol Cancer"},{"key":"9009_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101084","volume":"74","author":"H Zhao","year":"2024","unstructured":"Zhao H, Ling Y, He J, Dong J, Mo Q, Wang Y, et al. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma. Drug Resist Updat. 2024;74:101084.","journal-title":"Drug Resist Updat"},{"key":"9009_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee H, Kim B, Park J, Park S, Yoo G, Yum S, et al. Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Signal Transduct Target Ther. 2025;10:248.","journal-title":"Signal Transduct Target Ther"},{"key":"9009_CR6","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1158\/0008-5472.CAN-20-0378","volume":"80","author":"D Shiokawa","year":"2020","unstructured":"Shiokawa D, Sakai H, Ohata H, Miyazaki T, Kanda Y, Sekine S, et al. Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer. Cancer Res. 2020;80:4451\u201364.","journal-title":"Cancer Res"},{"key":"9009_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339.","journal-title":"Cell Stem Cell"},{"key":"9009_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"9009_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04116-6","volume":"12","author":"K Chen","year":"2021","unstructured":"Chen K, Zhang C, Ling S, Wei R, Wang J, Xu X. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance. Cell Death Dis. 2021;12:835.","journal-title":"Cell Death Dis"},{"key":"9009_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21:526\u201336.","journal-title":"Nat Rev Cancer"},{"key":"9009_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0092-8674(83)90040-5","volume":"33","author":"BT Pan","year":"1983","unstructured":"Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33:967\u201378.","journal-title":"Cell"},{"key":"9009_CR12","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"9009_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15016","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, Deng T, Liu R, Bai M, Zhou L, Wang X, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 2017;8:15016.","journal-title":"Nat Commun"},{"key":"9009_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102736","volume":"55","author":"V Ramakrishnan","year":"2020","unstructured":"Ramakrishnan V, Xu B, Akers J, Nguyen T, Ma J, Dhawan S, et al. Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas. EBioMedicine. 2020;55:102736.","journal-title":"EBioMedicine"},{"key":"9009_CR15","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1158\/0008-5472.CAN-18-4055","volume":"79","author":"M Shen","year":"2019","unstructured":"Shen M, Dong C, Ruan X, Yan W, Cao M, Pizzo D, et al. Chemotherapy-induced extracellular vesicle miRNAs promote breast cancer stemness by targeting ONECUT2. Cancer Res. 2019;79:3608\u201321.","journal-title":"Cancer Res"},{"key":"9009_CR16","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.7150\/jca.58846","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang H, Xie S, Liang B, Tang Q, Liu H, Wang D, et al. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-fluorouracil. J Cancer. 2021;12:4862\u201372.","journal-title":"J Cancer"},{"key":"9009_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41388-022-02528-y","volume":"42","author":"H Yang","year":"2023","unstructured":"Yang H, Zhao X, Liu J, Jin M, Liu X, Yan J, et al. TNF\u03b1-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity. Oncogene. 2023;42:35\u201348.","journal-title":"Oncogene"},{"key":"9009_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells9051261","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Dozmorov M, Oh Y. IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells. 2020;9:1261.","journal-title":"Cells"},{"key":"9009_CR19","doi-asserted-by":"publisher","first-page":"1300.e1320","DOI":"10.1053\/j.gastro.2019.12.020","volume":"158","author":"N Murphy","year":"2020","unstructured":"Murphy N, Carreras-Torres R, Song M, Chan AT, Martin RM, Papadimitriou N, et al. Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and Mendelian randomization analyses. Gastroenterology. 2020;158:1300.e1320.","journal-title":"Gastroenterology"},{"key":"9009_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.stem.2015.07.010","volume":"17","author":"F D\u2019Addio","year":"2015","unstructured":"D\u2019Addio F, La Rosa S, Maestroni A, Jung P, Orsenigo E, Ben Nasr M, et al. Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy. Cell Stem Cell. 2015;17:486\u201398.","journal-title":"Cell Stem Cell"},{"key":"9009_CR21","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1093\/bioinformatics\/bty1058","volume":"35","author":"A Cheng","year":"2019","unstructured":"Cheng A, Grant CE, Noble WS, Bailey TL. MoMo: discovery of statistically significant post-translational modification motifs. Bioinformatics. 2019;35:2774\u201382.","journal-title":"Bioinformatics"},{"key":"9009_CR22","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2023","unstructured":"Varadi M, Bertoni D, Magana P, Paramval U, Pidruchna I, Radhakrishnan M, et al. AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 2023;52:D368\u2013D375.","journal-title":"Nucleic Acids Res"},{"key":"9009_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/pmic.200300771","volume":"4","author":"N Blom","year":"2004","unstructured":"Blom N, Sicheritz-Pont\u00e9n T, Gupta R, Gammeltoft S, Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics. 2004;4:1633\u201349.","journal-title":"Proteomics"},{"key":"9009_CR24","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1074\/mcp.M111.012625","volume":"11","author":"C Song","year":"2012","unstructured":"Song C, Ye M, Liu Z, Cheng H, Jiang X, Han G, et al. Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol Cell Proteomics. 2012;11:1070\u201383.","journal-title":"Mol Cell Proteomics"},{"key":"9009_CR25","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.7150\/thno.103722","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Liu L, Gao X, Liu X, Dai Y, Mao Z, et al. A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles. Theranostics. 2025;15:3439\u201361.","journal-title":"Theranostics"},{"key":"9009_CR26","first-page":"1119","volume":"40","author":"X Gao","year":"2024","unstructured":"Gao X, Mao Z, Huang S, Huang G, Yang H. Cancer stem cell-derived exosomes promote drug resistance and invasion in colorectal cancer cells. Chin J Biochem Mol Biol. 2024;40:1119\u201331.","journal-title":"Chin J Biochem Mol Biol"},{"key":"9009_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fcell.2020.00286","volume":"8","author":"S Varma Shrivastav","year":"2020","unstructured":"Varma Shrivastav S, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020;8:286.","journal-title":"Front Cell Dev Biol"},{"key":"9009_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108984","volume":"27","author":"AR Leslie","year":"2024","unstructured":"Leslie AR, Ning S, Armstrong CM, D\u2019Abronzo LS, Sharifi M, Schaaf ZA, et al. IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer. iScience. 2024;27:108984.","journal-title":"iScience"},{"key":"9009_CR29","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.7150\/thno.57706","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu X, Adorno-Cruz V, Chang YF, Jia Y, Kawaguchi M, Dashzeveg NK, et al. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Theranostics. 2021;11:6632\u201343.","journal-title":"Theranostics"},{"key":"9009_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/sj.embor.7400048","volume":"5","author":"G Rena","year":"2004","unstructured":"Rena G, Bain J, Elliott M, Cohen P. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 2004;5:60\u201365.","journal-title":"EMBO Rep"},{"key":"9009_CR31","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41388-018-0557-9","volume":"38","author":"YB Hu","year":"2019","unstructured":"Hu YB, Yan C, Mu L, Mi YL, Zhao H, Hu H, et al. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance. Oncogene. 2019;38:1951\u201365.","journal-title":"Oncogene"},{"key":"9009_CR32","doi-asserted-by":"publisher","first-page":"12226","DOI":"10.1021\/acsnano.2c02971","volume":"16","author":"R Haldavnekar","year":"2022","unstructured":"Haldavnekar R, Venkatakrishnan K, Tan B. Cancer stem cell derived extracellular vesicles with self-functionalized 3D nanosensor for real-time cancer diagnosis: eliminating the roadblocks in liquid biopsy. ACS Nano. 2022;16:12226\u201343.","journal-title":"ACS Nano"},{"key":"9009_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","volume":"25","author":"A Soragni","year":"2025","unstructured":"Soragni A, Knudsen ES, O\u2019Connor TN, Tognon CE, Tyner JW, Gini B, et al. Acquired resistance in cancer: towards targeted therapeutic strategies. Nat Rev Cancer. 2025;25:613\u201333.","journal-title":"Nat Rev Cancer"},{"key":"9009_CR34","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ymthe.2025.01.023","volume":"33","author":"X Liu","year":"2025","unstructured":"Liu X, Yang J, Huang S, Hong Y, Zhu Y, Wang J, et al. Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRAS(G12D) protein to cancer-associated fibroblasts. Mol Ther. 2025;33:1134\u201353.","journal-title":"Mol Ther"},{"key":"9009_CR35","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","volume":"40","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Zhao Y, Chen Q, Zhu S, Niu Y, Ye Z, et al. Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 2021;40:5505\u201317.","journal-title":"Oncogene"},{"key":"9009_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s12276-023-01142-6","volume":"56","author":"X Li","year":"2024","unstructured":"Li X, Zhang CC, Lin XT, Zhang J, Zhang YJ, Yu HQ, et al. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Exp Mol Med. 2024;56:177\u201391.","journal-title":"Exp Mol Med"},{"key":"9009_CR37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Mousa M, Nadukkandy AS, Franssens L, Alnaqbi H, Alshamsi FY, et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023;23:544\u201364.","journal-title":"Nat Rev Cancer"},{"key":"9009_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101272","volume":"12","author":"S Bao","year":"2025","unstructured":"Bao S, Li Y, Liang Y, Dai J, Huang H, Ma B. A novel metabolite-interacting protein (MIP)-based molecular subtyping construction and validation of IGFBP3 as a MIP-related oncogene in colorectal cancer. Genes Dis. 2025;12:101272.","journal-title":"Genes Dis"},{"key":"9009_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/gutjnl-2020-323553","volume":"71","author":"LR Mangiapane","year":"2022","unstructured":"Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, et al. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2022;71:119\u201328.","journal-title":"Gut"},{"key":"9009_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ebiom.2019.09.045","volume":"49","author":"S Val\u00e8s","year":"2019","unstructured":"Val\u00e8s S, Bacola G, Biraud M, Touvron M, Bessard A, Geraldo F, et al. Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis. EBioMedicine. 2019;49:172\u201388.","journal-title":"EBioMedicine"},{"key":"9009_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2468-1253(23)00479-X","volume":"9","author":"S Napolitano","year":"2024","unstructured":"Napolitano S, Martini G, Ciardiello D, Del Tufo S, Martinelli E, Troiani T, et al. Targeting the EGFR signalling pathway in metastatic colorectal cancer. Lancet Gastroenterol Hepatol. 2024;9:664\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9009_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annonc.2019.10.007","volume":"31","author":"E Martinelli","year":"2020","unstructured":"Martinelli E, Ciardiello D, Martini G, Troiani T, Cardone C, Vitiello PP, et al. Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives. Ann Oncol. 2020;31:30\u201340.","journal-title":"Ann Oncol"},{"key":"9009_CR43","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","volume":"76","author":"CG Hubert","year":"2016","unstructured":"Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 2016;76:2465\u201377.","journal-title":"Cancer Res"},{"key":"9009_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122323","volume":"302","author":"Y Wu","year":"2023","unstructured":"Wu Y, Liang H, Luo A, Li Y, Liu Z, Li X, et al. Gelatin-based 3D biomimetic scaffolds platform potentiates culture of cancer stem cells in esophageal squamous cell carcinoma. Biomaterials. 2023;302:122323.","journal-title":"Biomaterials"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09009-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:58:00Z","timestamp":1789516680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09009-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9009"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09009-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experiments involving human tissue samples were performed following the Declaration of Helsinki. All human tissue samples used were collected after written INFORMED CONSENT was acquired from the relevant participants. All animal experiments were performed in accordance with the guidelines provided by the Animal Ethics Committee of the Shanghai University of Medicine and Health Sciences.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"804"}}